Phase-II study of AJA777 in patients with functional dyspepsia
Phase 2
- Conditions
- Functional dyspepsia (recruited according to the ROME III criteria)
- Registration Number
- JPRN-jRCT2080221822
- Lead Sponsor
- Ajinomoto Pharmaceuticals Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patient showing at least one of the following 4 symptoms from more than 24 weeks before enrollment.
One or more of:
- postprandial fullness
- early satiation
- upper abdominal pain
- upper abdominal discomfort
Exclusion Criteria
Patient showing symptoms of organic disease when upper gastrointestinal endoscopy is parfomed during baseline period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Elimination rate for each individual symptom
- Secondary Outcome Measures
Name Time Method